We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CMRA market cap is 1.38M. The company's latest EPS is USD -0.5979 and P/E is -0.07.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Total Revenue | 235k | 156k | 393k | 315k | 136k |
| Operating Income | -2.54M | -3.01M | -2.5M | -1.48M | -2.16M |
| Net Income | -3.36M | -3.05M | -2.57M | -1.5M | -2.24M |
| Year End 31 December 2022 | 2021 | 2022 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 320k | 633k |
| Operating Income | -6.59M | -11.97M |
| Net Income | -802k | -18.38M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Total Assets | 4.94M | 3.73M | 3M | 2.34M | 3.07M |
| Total Liabilities | 3.93M | 5.46M | 3.66M | 4M | 2.97M |
| Total Equity | -3.43M | -6.25M | -5.27M | -6.35M | -4.22M |
| Year End 31 December 2022 | 2021 | 2022 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 9.65M | 3.73M |
| Total Liabilities | 4.33M | 5.46M |
| Total Equity | 5.32M | -6.25M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Operating | -7.92M | -9.77M | -1.91M | -2.9M | -4.81M |
| Investing | -29k | -29k | -88k | -94k | -94k |
| Financing | 4.11M | 5.24M | 1.58M | 1.52M | 4.72M |
| Year End 31 December 2022 | 2021 | 2022 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Operating | N/A | -9.77M |
| Investing | N/A | -29k |
| Financing | N/A | 5.24M |
| Market Cap | 1.38M |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 1.94 |
| Price to Cash Ratio | 2.76 |
| Price to Book Ratio | -0.71 |
| Dividend Yield | - |
| Shares Outstanding | 30.74M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (30.62%) |
| Company Name | Comera Life Sciences Holdings Inc |
| Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
| Website | https://comeralifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
